Across
- 2. I am a highly potent topical PDE4 inhibitor that has been recently approved for the treatment of psoriasis
- 7. is a JAK family member that mediates signalling of IL-23. It is a target for Deucravacitinib
- 8. ring-like hypopigmentation zone around regressing psoriasis lesions
- 10. An oral manifestation of psoriasis
Down
- 1. "X" and Calcipotriol are used in the treatment of psoriasis. "X" is used in combination with steroids but inactives Calcipotriol. Identity "X"
- 3. _____is a potent neurokinin 1 receptor antagonist used for Psoriatic pruritis.
- 4. A breath test to screen for hepatotoxicity caused by MTX
- 5. Type of vessels described on Trichoscopy in Scalp psoriasis
- 6. A radiological sign named after a cartoon in psoriatic arthritis
- 9. NBUVB is used as a treatment modality in psoriasis during pregnancy but it can degrade ________ and hence requires supplementation.